Home
About
Services
Partners
Client Portfolio
News
Contact
HSBC HK shareholders mull legal action over dividend suspension
April 6, 2020
Uber connects out-of-work U.S. ride-hail drivers to delivery, production jobs
April 6, 2020
0
GSK to partner with Vir for potential COVID-19 treatments, invest $250 million
Published by
Muller&Green
at
April 6, 2020
Categories
RSS
Tags
British drugmaker GlaxoSmithKline will invest $250 million in Vir Biotechnology Inc and collaborate to develop potential treatments for COVID-19, the disease caused by the new coronavirus, the companies said on Monday.
Powered by
WPeMatico
Muller&Green
Related posts
March 16, 2025
CFR President Michael Froman on Trump, Global ‘Polyamory’ and AI
Read more
March 15, 2025
The Price of Gold Keeps Climbing. Here’s What to Know
Read more
March 14, 2025
American Airlines Plane Catches Fire at Denver Airport Gate
Read more